SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is currently in the spotlight as investors debate the impact of the upcoming CLARITY Act and the company's strategy of slowing its aggressive Ethereum accumulation. The community remains deeply divided, with some traders citing potential institutional pivot points and favorable tokenization trends, while others express frustration over share price performance compared to broader market gains and the company's dilution tactics.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors await critical extended follow-up data for its prostate cancer drug, CAN-2409, to be presented at an upcoming plenary session. The community is actively debating the potential for a practice-changing therapy, the durability of clinical outcomes, and the possibility of a premium acquisition by Big Pharma.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silver is experiencing a momentum breakout driven by intensifying industrial demand for AI infrastructure and renewed inflation hedging, leaving the community divided between aggressive buying of the dip and skepticism toward potential price manipulation. Investors are closely watching silvers decoupling from gold and its performance relative to rising treasury yields as the symbol gains traction as a strategic metal play.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility following a weak first-quarter earnings report, which highlighted a net loss and production delays at its Thompson Falls smelter. Despite these operational setbacks, retail investors remain divided between frustration over the missed targets and a bullish long-term thesis centered on government grants and the stock's role as a critical domestic supplier of antimony and tungsten.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is gaining traction as investors pivot toward software leaders amid aggressive institutional stake-building from major hedge funds. The community is focused on the stock's potential for a breakout as it tests key technical resistance levels, with strong debate over its valuation compared to hardware-heavy AI plays.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing significant community discussion due to its extremely tight float, with over 90% of shares reportedly held by the CEO and near-zero availability for shorting. Traders are closely watching for a potential parabolic squeeze, drawing comparisons to previous explosive meme stock moves and citing surging borrow fees as a catalyst for a possible short-covering rally.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense retail activity and a significant price rally following a 100 million dollar strategic investment from the Winklevoss Capital Fund, which investors are interpreting as a major signal of institutional conviction. While the community remains divided over the stock's long-term viability and recent performance, traders are actively discussing the potential for a short squeeze due to high short interest and anticipation surrounding upcoming regulatory developments in the crypto sector.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is trending as investors highlight the company's strong revenue growth and expanding role in providing reliability testing for AI and electric vehicle semiconductor applications. The community is actively comparing its valuation and growth metrics to industry peers, leading to discussions about whether the stock is undergoing a significant re-rating.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as market participants weigh strong quarterly growth and recent strategic partnerships against significant short interest and volatility. Investors are actively debating the company's valuation relative to competitors and monitoring the upcoming antitrust verdict involving its PriceRunner subsidiary as a critical catalyst for future price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Personalis to Participate in Upcoming Investor Events

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be participating in the following investor events: Craig Hallum...

Personalis Receives Medicare Coverage for NeXT Personal for Immunotherapy Monitoring Across Late-stage Solid Tumors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Centers for Medicare & Medicaid Services (CMS) Molecular Diagnostic Services Program...

Personalis (PSNL) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates

Personalis (PSNL) delivered earnings and revenue surprises of -26.09% and +7.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Personalis Reports First Quarter Results and Recent Highlights

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the first quarter ended March 31, 2026, highlighted recent...

Personalis, Inc. $PSNL Shares Sold by AIGH Capital Management LLC

AIGH Capital Management LLC lowered its position in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,900,000 shares of the company's stock after se...

Personalis (NASDAQ:PSNL) Stock Price Up 12.5% - Still a Buy?

Personalis (NASDAQ:PSNL) Shares Up 12.5% - Here's Why...

Personalis, Inc. (NASDAQ:PSNL) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven ratings firms that are covering the firm, MarketBeat.com reports. One...

Personalis (PSNL) Expected to Announce Quarterly Earnings on Thursday

Personalis (NASDAQ:PSNL) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Personalis (NASDAQ:PSNL) Trading Down 8.1% - What's Next?

Personalis (NASDAQ:PSNL) Trading Down 8.1% - Here's Why...

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Current Price	$6.53
Prev Close	$6.71
Open	$6.51
Dividend Yield	0.00%
50-Day Moving Average	$6.59
Beta	2.15
Avg. Volume	1.83M
PE Ratio	-6.60

52-Week High	$11.50
52-Week Low	$3.84
Market Capitalization	$702.68M
EPS (Annual)	-$0.9107
Price to Book	2.76
Revenue Per Employee	$267,876.92

PSNL
Personalis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PSNL News

PSNLPersonalis Inc